The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Structural and Functional Aspects of RGD-Containing Cyclic Pentapeptides as Highly Potent and Selective Integrin αVβ3Antagonists
Abstract
The α V β 3 integrin is implicated in human tumor metastasis and in angiogenesis. The design of low-molecular-mass α V β 3 antagonists by “spatial screening” led to the highly active peptides c(RGD F V) and c(RGDF V ). Here the influence of the amino acids in positions 4 and 5 flanking the RGD-sequence on the inhibition of vitronectin and fibrinogen binding to the isolated α V β 3 and α IIb β 3 receptors was investigated. The influence of the side chain and the backbone conformation on activity and selectivity was studied. The compounds were divided into conformational classes. For each class at least one representative peptide was subjected to detailed structure determination in solution. The peptides of classes 1, 2, and 3 show a βII‘/γ-turn arrangement with the d -amino acid in the i + 1 position of the βII‘-turn. By contrast, the peptides of class 4 reveal a modified βII‘/γ-turn pattern with glycine in the i + 1 position of the βII‘-turn and the d -amino acid in the i + 1 position of the γ-turn. Class 1 is divided into two subclasses: besides the βII‘/γ-turn arrangement a γ/γ-turn motif is found for two members of this class. Structure−activity relationship (SAR) investigations show that the amino acid in position 4 and the proton of the amide bond between residues 3 and 4 are essential for high biological activities toward α V β 3 . By contrast, the amino acid in position 5 has no influence on the activity. A bent conformation of the RGD-sequence, as observed for the peptides of classes 1 and 2, fits the α V β 3 better than the α IIb β 3 receptor and so increases the selectivity of these peptides.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NMR with Proteins and Nucleic Acids
Wüthrich, K. (1986) · Europhysics News · doi:10.1051/epn/19861701011 · Cited by 7,989
Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide
Merrifield, R. B. (1963) · Journal of the American Chemical Society · doi:10.1021/ja00897a025 · Cited by 7,647
New Perspectives in Cell Adhesion: RGD and Integrins
Ruoslahti, E., & Pierschbacher, M. D. (1987) · Science · doi:10.1126/science.2821619 · Cited by 4,865
Investigation of exchange processes by two-dimensional NMR spectroscopy
Jeener, J., Meier, B. H., Bachmann, P., & Ernst, R. R. (1979) · The Journal of Chemical Physics · doi:10.1063/1.438208 · Cited by 4,749
Requirement of Vascular Integrin α v β 3 for Angiogenesis
Brooks, P. C., Clark, R. A. F., & Cheresh, D. A. (1994) · Science · doi:10.1126/science.7512751 · Cited by 3,020
Folkman, J., & Shing, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49853-0 · Cited by 2,654
Solid phase peptide synthesis utilizing 9‐fluorenylmethoxycarbonyl amino acids
FIELDS, G. B., & NOBLE, R. L. (1990) · International Journal of Peptide and Protein Research · doi:10.1111/j.1399-3011.1990.tb00939.x · Cited by 2,493
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262
The nuclear overhauser effect in structural and conformational analysis
Lawless, G. (1989) · Journal of Organometallic Chemistry · doi:10.1016/0022-328x(89)85156-3 · Cited by 1,000
Pytela, R., Pierschbacher, M. D., Ginsberg, M. H., Plow, E. F., & Ruoslahti, E. (1986) · Science · doi:10.1126/science.2420006 · Cited by 925
Cited by
RGD modified polymers: biomaterials for stimulated cell adhesion and beyond
Hersel, U., Dahmen, C., & Kessler, H. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00343-0 · Cited by 2,582
Self-citationBioactive modification of poly (ethylene glycol) hydrogels for tissue engineering
Zhu, J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.044 · Cited by 1,457
Nicolas, J., Mura, S., Brambilla, D., Mackiewicz, N., & Couvreur, P. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35265f · Cited by 1,270
Synthetic polymer scaffolds for tissue engineering
Place, E. S., George, J. H., Williams, C. K., & Stevens, M. M. (2009) · Chemical Society Reviews · doi:10.1039/b811392k · Cited by 815
Advantages of RGD peptides for directing cell association with biomaterials
Bellis, S. L. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.029 · Cited by 745
Mas-Moruno, C., Rechenmacher, F., & Kessler, H. (2010) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152010794728639 · Cited by 647
Self-citationKapp, T. G., Rechenmacher, F., Neubauer, S., Maltsev, O. V., Cavalcanti-Adam, E. A., Zarka, R., Reuning, U., Notni, J., Wester, H.-J., Mas-Moruno, C., et al. (2017) · Scientific Reports · doi:10.1038/srep39805 · Cited by 620
Self-citationIshikawa, M., & Hashimoto, Y. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101356p · Cited by 619
Functionalized micellar systems for cancer targeted drug delivery
Sutton, D., Nasongkla, N., Blanco, E., & Gao, J. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9223-y · Cited by 557
99mTc-Labeled Small Peptides as Diagnostic Radiopharmaceuticals
Liu, S., & Edwards, D. S. (1999) · Chemical Reviews · doi:10.1021/cr980436l · Cited by 511
Ponnuswamy, N., Bastings, M. M. C., Nathwani, B., Ryu, J. H., Chou, L. Y. T., Vinther, M., Li, W. A., Anastassacos, F. M., Mooney, D. J., & Shih, W. M. (2017) · Nature Communications · doi:10.1038/ncomms15654 · Cited by 508
Mechanisms of drug release in nanotherapeutic delivery systems
Wong, P. T., & Choi, S. K. (2015) · Chemical Reviews · doi:10.1021/cr5004634 · Cited by 507
Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
Murphy, E. A., Majeti, B. K., Barnes, L. A., Makale, M., Weis, S. M., Lutu-Fuga, K., Wrasidlo, W., & Cheresh, D. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803728105 · Cited by 455
Horii, A., Wang, X., Gelain, F., & Zhang, S. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000190 · Cited by 449
cRGD‐Functionalized Polymer Micelles for Targeted Doxorubicin Delivery
Nasongkla, N., Shuai, X., Ai, H., Weinberg, B. D., Pink, J., Boothman, D. A., & Gao, J. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200460800 · Cited by 434
Haubner, R., Finsinger, D., & Kessler, H. (1997) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199713741 · Cited by 430
Self-citationMultivalent Effects of RGD Peptides Obtained by Nanoparticle Display
Montet, X., Funovics, M., Montet-Abou, K., Weissleder, R., & Josephson, L. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060515m · Cited by 388
Inhibition of Microglial Phagocytosis Is Sufficient To Prevent Inflammatory Neuronal Death
Neher, J. J., Neniskyte, U., Zhao, J.-W., Bal-Price, A., Tolkovsky, A. M., & Brown, G. C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003600 · Cited by 373
Lateral spacing of integrin ligands influences cell spreading and focal adhesion assembly
Cavalcanti-Adam, E. A., Micoulet, A., Blümmel, J., Auernheimer, J., Kessler, H., & Spatz, J. P. (2006) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2005.09.011 · Cited by 366
Self-citationLiu, S. (2009) · Bioconjugate Chemistry · doi:10.1021/bc900167c · Cited by 344
Arnold, M., Hirschfeld-Warneken, V. C., Lohmüller, T., Heil, P., Blümmel, J., Cavalcanti-Adam, E. A., López-García, M., Walther, P., Kessler, H., Geiger, B., et al. (2008) · Nano Letters · doi:10.1021/nl801483w · Cited by 305
Self-citationLigands for Mapping αvβ3-Integrin Expression in Vivo
Schottelius, M., Laufer, B., Kessler, H., & Wester, H.-J. (2009) · Accounts of Chemical Research · doi:10.1021/ar800243b · Cited by 294
Self-citationRegenerative Therapies for Central Nervous System Diseases: a Biomaterials Approach
Tam, R. Y., Fuehrmann, T., Mitrousis, N., & Shoichet, M. S. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.237 · Cited by 293
Thumshirn, G., Hersel, U., Goodman, S. L., & Kessler, H. (2003) · Chemistry – A European Journal · doi:10.1002/chem.200204304 · Cited by 269
Self-citationTesauro, D., Accardo, A., Diaferia, C., Milano, V., Guillon, J., Ronga, L., & Rossi, F. (2019) · Molecules · doi:10.3390/molecules24020351 · Cited by 225
MFG-E8 Mediates Primary Phagocytosis of Viable Neurons during Neuroinflammation
Fricker, M., Neher, J. J., Zhao, J.-W., Théry, C., Tolkovsky, A. M., & Brown, G. C. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4837-11.2012 · Cited by 218
Peptide ligand-mediated targeted drug delivery of nanomedicines
Jiang, Z., Guan, J., Qian, J., & Zhan, C. (2019) · Biomaterials Science · doi:10.1039/c8bm01340c · Cited by 172
Protease-Resistant Peptides for Targeting and Intracellular Delivery of Therapeutics
Lucana, M. C., Arruga, Y., Petrachi, E., Roig, A., Lucchi, R., & Oller-Salvia, B. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122065 · Cited by 102
Biscaglia, F., Ripani, G., Rajendran, S., Benna, C., Mocellin, S., Bocchinfuso, G., Meneghetti, M., Palleschi, A., & Gobbo, M. (2019) · ACS Applied Nano Materials · doi:10.1021/acsanm.9b01392 · Cited by 54
Zhang, C.-X., Zhao, W.-Y., Liu, L., Ju, R.-J., Mu, L.-M., Zhao, Y., Zeng, F., Xie, H.-J., Yan, Y., & Lu, W.-L. (2015) · Oncotarget · doi:10.18632/oncotarget.5354 · Cited by 38
Metadata
- Authors
- Haubner, R., Gratias, R., Diefenbach, B., Goodman, S. L., Jonczyk, A., & Kessler, H.
- Venue
- Journal of the American Chemical Society
- Publisher
- American Chemical Society (ACS)
- Published
- 1996-01-01
- Volume
- 118
- Issue
- 32
- Pages
- 7461-7472
- ISSN
- 0002-7863 (ISSN-L)
- 1520-5126
- OpenAlex
- W2005425959
- Cited by
- 582
- References
- 39
- FWCI
- 4.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.